Tag: artificial intelligence in biopharmaceuticals market forecast

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Artificial Intelligence (AI) In Biopharmaceuticals Market Size Forecast: How Big Could The Market Get By 2030?

The artificial intelligence (AI) in biopharmaceuticals market has experienced substantial growth over recent years. This market is anticipated to expand from $2.1 billion in 2025 to $2.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.0%. Contributing to this historic expansion are factors like the initial adoption of AI in pharmaceutical research, enhanced computational power, increased funding for biopharmaceutical R&D, the incorporation of omics data, and the proliferation of cloud-based data storage.

The artificial intelligence (ai) in biopharmaceuticals market is expected to undergo significant expansion in the coming years. It is projected to achieve a valuation of $8.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This anticipated growth during the forecast period can be attributed to advancements in machine learning algorithms, the increasing availability of AI-enabled laboratory equipment, wider adoption of predictive analytics, the rise of collaborative AI-biopharma platforms, and government incentives for AI-driven healthcare. Prominent trends within this period are AI-driven drug discovery, the application of predictive analytics in clinical trials, automation of laboratory processes, integration of real-world data, and optimization of personalized treatments.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Factors: What’s Supporting Expansion?

The rising incidence of chronic diseases is projected to propel the growth of artificial intelligence (AI) in biopharmaceuticals market going forward. Chronic diseases are long-lasting conditions that typically progress slowly and can endure for years or even a lifetime, often stemming from lifestyle factors, an aging population, genetic predispositions, and environmental factors. AI in biopharmaceuticals is increasingly leveraged for managing chronic diseases because it analyzes large volumes of diverse data sources, identifies patterns, and personalizes treatment approaches. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition in 2023. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases drives the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Artificial Intelligence (AI) In Biopharmaceuticals Market Segment Landscape And Growth Outlook

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Artificial Intelligence (AI) In Biopharmaceuticals Market Industry Trends: What’s Reshaping Demand?

Major companies engaged in artificial intelligence within the biopharmaceutical sector are prioritizing the development of cutting-edge innovations, including AI-powered solutions for target and lead identification. These advancements aim to accelerate drug discovery and precision medicine, thereby transforming organizations across the life sciences. The solutions designed for drug discovery and precision medicine encompass a range of novel approaches for creating new medications and customizing therapies for individual patients. A notable example occurred in May 2023, when Google LLC, a US-based provider of cloud computing services, launched two new AI-driven offerings called target and lead identification suites. These tools are engineered to help researchers anticipate and understand protein structures, which forms a foundational aspect of drug development. Additionally, this suite will facilitate researchers in ingesting, storing, analyzing, and sharing substantial volumes of genomic data, an element critical for precision medicine. The objective of these tools is to streamline the drug discovery process, reduce associated costs, and expedite the market availability of new treatments. Through efficient data management, accurate protein structure predictions, and advanced genomic analysis features, these tools aspire to revolutionize drug development workflows and improve patient outcomes.

Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

View The Full Artificial Intelligence (AI) In Biopharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Artificial Intelligence (AI) In Biopharmaceuticals Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Artificial Intelligence (AI) In Biopharmaceuticals Market Revenue Growth Supported By A CAGR Of 8.77% Through 2030

The market for artificial intelligence (AI) in biopharmaceuticals has experienced exponential expansion in recent years. Projected to increase from $2.1 billion in 2025 to $2.79 billion in 2026, this growth represents a compound annual growth rate (CAGR) of 33.0%. Factors driving progress during the historical period include the early adoption of AI within pharmaceutical research, enhanced computational capabilities, heightened investment in biopharmaceutical research and development, the integration of omics data, and the proliferation of cloud-based data storage solutions.

The artificial intelligence (AI) sector within biopharmaceuticals is poised for rapid expansion over the coming years. By 2030, it is projected to reach a valuation of $8.77 billion, reflecting a compound annual growth rate (CAGR) of 33.1%. This anticipated growth during the forecast period is fueled by several key factors, such as progress in machine learning algorithms, broader deployment of AI-powered laboratory tools, a greater reliance on predictive analytics, a surge in collaborative initiatives between AI firms and biopharma companies, and government support for AI-driven healthcare solutions. Notable developments shaping this period include AI-facilitated drug discovery, the application of predictive analytics to clinical trials, lab automation, the use of real-world data, and customized approaches to treatment optimization.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing occurrence of chronic illnesses is set to boost the expansion of artificial intelligence (AI) within the biopharmaceuticals sector in the coming years. Chronic diseases, which are persistent conditions that typically advance gradually and can last for years or a lifetime, stem from factors such as lifestyle choices, an aging demographic, genetic tendencies, and environmental influences. AI’s role in biopharmaceuticals has become crucial for managing these conditions because it processes extensive and varied data sets, uncovers trends, and tailors treatment strategies to individuals. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a U.S. federal agency, reported that about 194 million American adults—equivalent to 76.4%—had at least one chronic condition in 2023. This prevalence varied by age, affecting 59.5% of younger adults, 78.4% of those in midlife, and 93.0% of older individuals. Consequently, the rising prevalence of chronic diseases is fueling the growth of artificial intelligence (AI) in the biopharmaceuticals market.

Artificial Intelligence (AI) In Biopharmaceuticals Market Segment Performance And Strategic Opportunities

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Artificial Intelligence (AI) In Biopharmaceuticals Market Trends Reshaping Industry Growth

Key industry players in the artificial intelligence (AI) sector for biopharmaceuticals are concentrating on creating cutting-edge innovations, including AI-driven solutions for target and lead identification, which accelerate drug discovery and enable precision medicine, thereby transforming life sciences organizations. These drug discovery and precision medicine solutions incorporate a range of novel methods for developing new medications and customizing treatments for individual patients. For example, in May 2023, Google LLC, a U.S.-based cloud computing provider, introduced two new AI-powered tools—the target and lead identification suites—designed to assist researchers in predicting and comprehending protein structures, a critical component of drug development. Furthermore, these tools facilitate the ingestion, storage, analysis, and sharing of extensive genomic data, which is essential for precision medicine, and they aim to expedite the drug discovery process, lower expenses, and accelerate the availability of new therapies. Through efficient data management, precise protein structure predictions, and advanced genomic analysis, these innovations are intended to transform drug development workflows and enhance patient outcomes.

Artificial Intelligence (AI) In Biopharmaceuticals Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Access The Complete Artificial Intelligence (AI) In Biopharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Artificial Intelligence (AI) In Biopharmaceuticals Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Artificial Intelligence (AI) In Biopharmaceuticals Market Expected To Reach Based On Its 2026 Value?

The market for artificial intelligence (ai) in biopharmaceuticals has experienced significant expansion in recent years. This sector is anticipated to expand from $2.1 billion in 2025 to $2.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 33.0%. Historically, this growth has been driven by factors such as the early adoption of ai in pharma research, increasing computational power, rising investment in biopharmaceutical r&d, integration of omics data, and the growth of cloud-based data storage.

The artificial intelligence (ai) in biopharmaceuticals market size is projected to experience substantial expansion in the coming years. This market is set to reach $8.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This anticipated growth throughout the forecast period stems from factors such as advancements in machine learning algorithms, the expansion of ai-enabled lab equipment, wider adoption of predictive analytics, an increase in collaborative ai-biopharma platforms, and government incentives supporting ai-driven healthcare. Key trends shaping the forecast period encompass ai-driven drug discovery, predictive analytics applied to clinical trials, enhanced automation in laboratory processes, integration of real-world data, and the optimization of personalized treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

What Primary Drivers Are Shaping The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The increasing incidence of chronic illnesses is projected to fuel the expansion of the artificial intelligence (AI) in biopharmaceuticals market moving forward. These long-term conditions typically advance gradually and can persist for years or even a lifetime. Their development stems from factors such as lifestyle choices, an aging demographic, genetic predispositions, and environmental influences. AI in biopharmaceuticals is increasingly utilized for managing chronic diseases due to its capacity to analyze vast amounts of diverse data, identify patterns, and personalize treatment approaches. For instance, in April 2025, data from the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated that in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was recorded as 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. As a result, the escalating prevalence of chronic diseases is a significant driver for the growth of artificial intelligence (AI) in the biopharmaceuticals market.

How Are Segments Identified Within The Artificial Intelligence (AI) In Biopharmaceuticals Market Segment Framework?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What Trends Are Affecting The Growth Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies in biopharmaceuticals utilizing artificial intelligence (AI) are concentrating on developing innovative advancements, such as AI-powered target and lead identification suites, to accelerate drug discovery and precision medicine, thereby transforming life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For instance, in May 2023, Google LLC, a US-based provider of cloud computing services, launched two new AI-powered tools called target and lead identification suites, designed to help researchers predict and understand the structure of proteins, which is a fundamental part of drug development. Additionally, this suite will assist researchers in ingesting, storing, analyzing, and sharing large amounts of genomic data, which is crucial for precision medicine. Also, these tools aim to streamline the drug discovery process, reduce costs, and bring new treatments to market faster. By providing efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and improve patient outcomes.

Who Are The Companies Competing Within The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Get The Full Artificial Intelligence (AI) In Biopharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Region Represents The Largest Share Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI) In Biopharmaceuticals Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2026, By The Business Research Company

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Artificial Intelligence (AI) In Biopharmaceuticals Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The market size for artificial intelligence (AI) in biopharmaceuticals has seen substantial expansion in recent years. This market is anticipated to expand from $2.1 billion in 2025 to $2.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 33.0%. The growth observed in previous periods is a result of the early embrace of AI in pharmaceutical research, enhanced computational power, increased investment in biopharmaceutical research and development (R&D), the integration of omics data, and the proliferation of cloud-based data storage.

The artificial intelligence (AI) in biopharmaceuticals market is set for significant expansion in the coming years. It is projected to reach $8.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 33.1%. This anticipated growth throughout the forecast period stems from advancements in machine learning algorithms, the increasing availability of AI-enabled laboratory equipment, a greater embrace of predictive analytics, the emergence of collaborative AI-biopharma platforms, and government incentives supporting AI in healthcare. Prominent trends for the forecast period involve AI-driven drug discovery, the application of predictive analytics in clinical trials, the automation of laboratory processes, the integration of real-world data, and the optimization of personalized treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

What Major Drivers Are Influencing Demand In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The increasing occurrence of chronic diseases is projected to drive the expansion of the artificial intelligence (AI) in biopharmaceuticals market moving ahead. These are enduring conditions that typically advance gradually, potentially lasting for years or a lifetime, often stemming from lifestyle choices, an aging populace, genetic susceptibilities, and environmental influences. AI within biopharmaceuticals is increasingly employed for managing chronic diseases by analyzing vast amounts of varied data, pinpointing patterns, and customizing treatment strategies. For instance, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that in 2023, approximately 194 million U.S. adults, constituting 76.4%, had at least one chronic condition. The prevalence stood at 59.5% for young adults, 78.4% for midlife adults, and 93.0% for older adults. Consequently, the rising prevalence of chronic diseases stands as a significant driver for the growth of the artificial intelligence (AI) in the biopharmaceuticals market.

What Major Segment Divisions Exist Within The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

How Are Trends Shaping The Direction Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Leading companies in artificial intelligence (AI) within biopharmaceuticals are focused on developing cutting-edge advancements, such as AI-powered solutions for target and lead identification, to accelerate drug discovery and precision medicine, ultimately transforming life sciences organizations. These solutions for drug discovery and precision medicine encompass a range of innovative methods for developing new medications and tailoring treatments to individual patients. For instance, in May 2023, Google LLC, a US-based provider of cloud computing services, launched two new AI tools called target and lead identification suites. These tools are designed to assist researchers in predicting and understanding protein structures, a fundamental aspect of drug development. Additionally, this suite will enable researchers to ingest, store, analyze, and share vast amounts of genomic data, which is crucial for precision medicine. These tools also aim to streamline the drug discovery process, reduce expenses, and bring new treatments to market more quickly. By providing efficient data management, precise predictions of protein structures, and advanced genomic analysis capabilities, these tools intend to revolutionize drug development processes and enhance patient outcomes.

Which Companies Are Leading Innovation In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Read the full artificial intelligence (ai) in biopharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI) In Biopharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2026, By The Business Research Company

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in biopharmaceuticals market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Artificial Intelligence (AI) In Biopharmaceuticals Market size between 2026 and 2035?

The artificial intelligence (AI) in biopharmaceuticals market size has seen remarkable growth in recent years. It is projected to increase from $2.1 billion in 2025 to $2.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 33.0%. The expansion observed historically can be linked to factors such as the early incorporation of AI in pharmaceutical research, advancements in computational capabilities, a surge in investment within biopharmaceutical R&D, the integration of omics data, and the proliferation of cloud-based data storage.

The artificial intelligence (ai) in biopharmaceuticals market is anticipated to experience substantial growth over the upcoming years. Its valuation is forecast to climb to $8.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 33.1%. This expansion during the projection period is primarily driven by enhancements in machine learning algorithms, the increasing deployment of AI-enabled laboratory equipment, broader integration of predictive analytics, the rise of collaborative AI-biopharma platforms, and governmental encouragement for AI-driven healthcare initiatives. Significant developments expected throughout this period include AI-powered drug discovery, the application of predictive analytics in clinical trials, the automation of laboratory procedures, the incorporation of real-world data, and the refinement of personalized treatment strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Drivers Are Impacting Market Performance In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The increasing incidence of chronic illnesses is anticipated to fuel the expansion of artificial intelligence (AI) in the biopharmaceuticals market in the foreseeable future. These are enduring health conditions characterized by a gradual progression, potentially lasting for many years or throughout an individual’s life. Their development is often linked to lifestyle choices, an increasing elderly demographic, genetic susceptibilities, and environmental influences. Artificial intelligence in biopharmaceuticals is increasingly being utilized for chronic disease management, given its capability to analyze extensive and varied data, discern underlying patterns, and tailor therapeutic strategies. For example, data from April 2025, provided by the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated that in 2023, around 194 million U.S. adults, representing 76.4% of the population, reported suffering from at least one chronic ailment. Specifically, the prevalence was noted as 59.5% among young adults, 78.4% among midlife adults, and a significant 93.0% among older adults. Consequently, the expanding occurrence of chronic diseases is a primary driver for the advancement of artificial intelligence (AI) within the biopharmaceuticals market.

What Segment Types Are Examined In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Drug Discovery, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

Which Trends Are Influencing The Performance And Direction Of The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Leading companies in artificial intelligence (AI) within the biopharmaceutical sector are concentrating on developing innovative advancements, such as AI-powered solutions for target and lead identification suites, to accelerate drug discovery and precision medicine, thus transforming life sciences organizations. These solutions for drug discovery and precision medicine involve a range of inventive approaches to developing new drugs and customizing treatments for individual patients. For example, in May 2023, Google LLC, a US-based cloud computing services provider, launched two new AI-powered tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding the structure of proteins, a fundamental component of drug development. Additionally, this suite will help researchers ingest, store, analyze, and share vast amounts of genomic data, which is vital for precision medicine. These tools also aim to streamline the drug discovery process, reduce costs, and expedite the market entry of new treatments. By offering efficient data management, accurate protein structure predictions, and advanced genomic analysis capabilities, these tools aspire to revolutionize drug development processes and enhance patient outcomes.

Who Are The Core Companies Influencing Trends In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (ai) in biopharmaceuticals market are Exscientia Limited, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Regions Are Projected To Dominate The Artificial Intelligence (AI) In Biopharmaceuticals Market In The Coming Years?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence (AI) In Biopharmaceuticals Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2026, By The Business Research Company

Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Artificial Intelligence In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in biopharmaceuticals market from 2025–2034 with trusted insights from The Business Research Company

How Will The Artificial Intelligence (AI) In Biopharmaceuticals Market Size Evolve Between Now And 2029?

The artificial intelligence (AI) in biopharmaceuticals market size has experienced significant expansion in recent years. This market is forecast to grow from $1.59 billion in 2024 to $2.1 billion in 2025, at a compound annual growth rate (CAGR) of 32.2%. Historically, this growth can be attributed to advancements in computational power, biomedical data explosion, the precision medicine paradigm, and regulatory support and guidance.

The artificial intelligence (AI) in biopharmaceuticals market is anticipated to experience substantial growth over the upcoming years. It is projected to expand to $6.58 billion by 2029, achieving a compound annual growth rate (CAGR) of 33.0%. This expansion during the forecast period is largely due to advancements in computational biology, integration of multi-modal data, convergence of AI and life sciences, regulatory support and frameworks, and ethical and fair AI principles. Significant trends expected in the forecast period comprise integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Key Drivers Are Powering Growth In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The increasing occurrence of chronic illnesses is anticipated to boost the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. These are enduring health conditions that typically advance gradually and can last for extended periods or an entire life. Their origins stem from elements such as lifestyle choices, a progressively older demographic, inherited susceptibilities, and environmental influences. Artificial intelligence (AI) in biopharmaceuticals finds increasing application in the management of chronic diseases due to its capability to analyze extensive volumes of varied data, pinpoint recurring patterns, and tailor treatment strategies. As an illustration, in November 2023, data from the Department of Health and Human Services, a US-based government entity, indicated an 11 percent rise in newly documented chronic hepatitis B cases in 2022 when contrasted with figures from 2021. Consequently, the expanding occurrence of chronic illnesses acts as a key catalyst for the growth of the artificial intelligence (AI) in biopharmaceuticals market.

How Is The Global Artificial Intelligence (AI) In Biopharmaceuticals Market Structured By Key Segments?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What Future-Focused Trends Are Anticipated In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major artificial intelligence (AI) companies active in biopharmaceuticals are concentrating on developing innovative advancements, such as AI-powered target and lead identification suite solutions, to accelerate drug discovery and precision medicine and thereby transform life sciences organizations. These solutions for drug discovery and precision medicine involve various innovative methods for creating new drugs and customizing treatments for individual patients. For example, in May 2023, Google LLC, a US-based provider of cloud computing services, introduced two new AI-powered tools named target and lead identification suites, engineered to assist researchers in predicting and understanding protein structures, a foundational component of drug development. Additionally, this suite will support researchers in ingesting, storing, analyzing, and sharing large volumes of genomic data, which is essential for precision medicine. These tools also aim to streamline the drug discovery process, cut costs, and expedite the market launch of new treatments. By offering efficient data management, accurate protein structure predictions, and advanced genomic analysis capabilities, these tools seek to revolutionize drug development processes and improve patient outcomes.

Which Companies Hold A Competitive Edge In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

Which Region Is Expected To Lead The Artificial Intelligence (AI) In Biopharmaceuticals Market In The Next Few Years?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company

Artificial Intelligence Ai In Agriculture Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-agriculture-global-market-report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Artificial Intelligence In Cardiology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cardiology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Artificial Intelligence (AI) In Biopharmaceuticals Market By 2029?

The artificial intelligence (AI) in biopharmaceuticals market has experienced rapid expansion recently. Its size is projected to increase from $1.59 billion in 2024 to $2.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.2%. This historical growth has been driven by several factors, including advancements in computational power, the biomedical data explosion, the precision medicine paradigm, and regulatory support and guidance.

The artificial intelligence (AI) in biopharmaceuticals market is anticipated to undergo significant growth over the next few years, with its size expected to ascend to $6.58 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 33.0%. This expansion during the forecast period is primarily driven by breakthroughs in computational biology, the incorporation of multi-modal data, the convergence of AI and life sciences, supportive regulatory frameworks, and the implementation of ethical and fair AI principles. Noteworthy trends during this time encompass the integration of multi-omics data, AI-powered drug design and discovery, the acceptance of explainable AI by regulators, ongoing technological advancements, developments in regulation, and the identification of new opportunities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp

Which Industry Drivers Are Expected To Accelerate The Artificial Intelligence (AI) In Biopharmaceuticals Market From 2025 To 2029?

The increasing incidence of chronic illnesses is anticipated to fuel the expansion of artificial intelligence (AI) in biopharmaceuticals market in the future. These are enduring health conditions that typically develop gradually and can last for extended periods or even a person’s entire life. Their emergence is linked to lifestyle choices, an older demographic, genetic susceptibilities, and environmental influences. Artificial intelligence in biopharmaceuticals finds increasing application in managing chronic diseases due to its capacity to analyze vast amounts of varied data, detect underlying patterns, and tailor therapeutic strategies. For example, data from November 2023 from the Department of Health and Human Services, a US-based government department, indicated an 11 percent rise in new chronic hepatitis B cases in 2022 compared to 2021. Consequently, the rising occurrence of chronic ailments acts as a significant catalyst for the growth of artificial intelligence (AI) in the biopharmaceuticals market.

What Are The Emerging Segments Gaining Attention In The Artificial Intelligence (AI) In Biopharmaceuticals Market?

The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –

1) By Offering: Hardware, Software, Services

2) By Deployment: Cloud, On-Premises

3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies

4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine

5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes

Subsegments:

1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions

2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions

3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services

What Trends Are Redefining The Artificial Intelligence (AI) In Biopharmaceuticals Market Dynamics?

Leading companies leveraging artificial intelligence (AI) in biopharmaceuticals are concentrating on creating pioneering advancements, such as AI-driven target and lead identification suite solutions, to accelerate drug discovery and precision medicine and, in turn, transform life sciences organizations. These solutions for drug discovery and precision medicine integrate diverse innovative methodologies for developing novel drugs and customizing treatments for individual patients. As an illustration, in May 2023, Google LLC, a US-based cloud computing service provider, unveiled two new AI-powered instruments, known as target and lead identification suites, intended to aid researchers in forecasting and deciphering protein structures, a foundational element of drug development. Furthermore, this suite will empower researchers to ingest, store, analyze, and share vast quantities of genomic data, which is vital for precision medicine. These tools are also designed to streamline the drug discovery process, minimize costs, and expedite the introduction of new treatments to the market. By offering efficient data management, precise predictions of protein structures, and sophisticated genomic analysis capabilities, these tools aspire to revolutionize drug development workflows and enhance patient outcomes.

Who Are The Top Performing Companies In The Artificial Intelligence (AI) In Biopharmaceuticals Market In Recent Years?

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report

What Regional Growth Trends Are Shaping The Artificial Intelligence (AI) In Biopharmaceuticals Market Outlook?

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Artificial Intelligence (AI) In Biopharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Biopharmaceuticals Market 2025, By The Business Research Company

Artificial Intelligence Ai In Agriculture Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-agriculture-global-market-report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Artificial Intelligence In Cardiology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cardiology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model